Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for COGT
| Stock Name | Cogent Biosciences Inc |
| Ticker | COGT(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US19240Q2012 |
Show aggregate COGT holdings
News associated with COGT
- Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $20.00
- Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lifted by equities researchers at Guggenheim from $17.00 to $20.00 in a research note issued on Monday, MarketBeat.com reports. The firm currently has a “buy” rating on the technology company’s stock. Guggenheim’s price objective indicates a potential upside of 63.53% from the stock’s previous […] - 2025-08-27 02:08:48
- Arizona State Retirement System Has $123,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT)
- Arizona State Retirement System grew its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 18.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,567 shares of the technology company’s stock after purchasing an additional 3,142 shares during the […] - 2025-07-24 04:38:50
- Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $22.00 at Citigroup
- Cogent Biosciences (NASDAQ:COGT – Free Report) had its price objective boosted by Citigroup from $15.00 to $22.00 in a research note issued to investors on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the technology company’s stock. Several other equities analysts have also recently commented on COGT. HC Wainwright boosted their target price […] - 2025-07-21 04:55:01
- Analysts See 19% Gains Ahead For FHLC
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
- Cogent Biosciences (NASDAQ:COGT) Trading 9% Higher Following Analyst Upgrade
- Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report)’s share price traded up 9% during trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $25.00 to $29.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Cogent Biosciences traded as high as $10.12 and last traded […] - 2025-07-11 02:22:49
- Cogent Biosciences (NASDAQ:COGT) Sees Large Volume Increase on Analyst Upgrade
- Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) saw strong trading volume on Tuesday after HC Wainwright raised their price target on the stock from $12.00 to $22.00. HC Wainwright currently has a buy rating on the stock. 4,989,146 shares changed hands during mid-day trading, an increase of 236% from the previous session’s […] - 2025-07-10 02:52:43
- Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of “Moderate Buy” by Brokerages
- Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. […] - 2025-07-08 05:26:50
- Pre-Market Most Active for Jul 7, 2025 : TSLL, TSLA, TSLQ, COGT, BBAI, SQQQ, NVDA, HLN, CRCL, NIO, OSCR, QBTS
- The NASDAQ 100 Pre-Market Indicator is down -99.52 to 22,767.45. The total Pre-Market volume is currently 171,325,842 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -1.4 at $10.13, with 43,244,717 s - 2025-07-07 09:29:58
- Wedbush Reiterates “Neutral” Rating for Cogent Biosciences (NASDAQ:COGT)
- Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at Wedbush in a report issued on Monday,RTT News reports. They presently have a $10.00 target price on the technology company’s stock. Wedbush’s price objective would suggest a potential upside of 38.50% from the stock’s previous close. A number […] - 2025-07-02 02:56:48
- Needham & Company LLC Reiterates Hold Rating for Cogent Biosciences (NASDAQ:COGT)
- Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “hold” rating restated by equities research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. Several other research firms also recently commented on COGT. Scotiabank started coverage on Cogent Biosciences in a research note on Friday, March 7th. They […] - 2025-06-19 02:26:49
- Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lessened by Wellington Management Group LLP
- Wellington Management Group LLP decreased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 16.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 284,850 shares of the technology company’s stock after selling 57,473 shares during the quarter. Wellington Management Group LLP’s holdings in Cogent Biosciences were worth $2,222,000 at […] - 2025-06-06 05:34:49
- Nuveen Asset Management LLC Has $2.44 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)
- Nuveen Asset Management LLC lessened its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 0.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 313,099 shares of the technology company’s stock after selling 1,896 shares during the quarter. Nuveen Asset Management LLC’s holdings in Cogent Biosciences were worth $2,442,000 at […] - 2025-06-03 04:58:48
- Cogent Biosciences, Inc. (NASDAQ:COGT) Position Increased by ProShare Advisors LLC
- ProShare Advisors LLC increased its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 30.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,074 shares of the technology company’s stock after purchasing an additional 7,267 shares during the period. […] - 2025-06-01 05:44:58
- Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts
- Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-05-26 05:29:06
- HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price
- Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. HC Wainwright’s price target would indicate a potential upside of […] - 2025-05-22 03:12:43
- 30,300 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Purchased by OMERS ADMINISTRATION Corp
- OMERS ADMINISTRATION Corp purchased a new position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,300 shares of the technology company’s stock, valued at approximately $236,000. Several other hedge funds […] - 2025-05-21 05:26:52
- D. E. Shaw & Co. Inc. Decreases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)
- D. E. Shaw & Co. Inc. lowered its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 25.6% during the 4th quarter, HoldingsChannel reports. The fund owned 339,988 shares of the technology company’s stock after selling 117,240 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Cogent Biosciences were worth $2,652,000 […] - 2025-05-20 04:57:06
- Schonfeld Strategic Advisors LLC Takes $78,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT)
- Schonfeld Strategic Advisors LLC purchased a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the technology company’s stock, valued at approximately $78,000. A number of […] - 2025-05-15 05:40:52
- Dimensional Fund Advisors LP Sells 48,771 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
- Dimensional Fund Advisors LP lessened its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 743,652 shares of the technology company’s stock after selling 48,771 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Cogent Biosciences were worth $5,800,000 as of its most […] - 2025-05-12 04:50:50
- Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT)
- Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors purchased 20,016 call options on the company. This is an increase of 5,019% compared to the typical volume of 391 call options. Cogent Biosciences Stock Up 8.1 % Shares of NASDAQ:COGT opened at $5.63 on […] - 2025-05-02 02:09:01
- Legal & General Group Plc Sells 2,304 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
- Legal & General Group Plc cut its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,541 shares of the technology company’s stock after selling 2,304 shares during […] - 2025-04-30 04:46:50
- Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Analysts
- Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-04-29 04:41:03
- Alliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
- Alliancebernstein L.P. lifted its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 466.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,942 shares of the technology company’s stock after acquiring an additional 382,882 shares during the quarter. Alliancebernstein […] - 2025-04-15 04:52:58
- KLP Kapitalforvaltning AS Acquires Shares of 11,300 Cogent Biosciences, Inc. (NASDAQ:COGT)
- KLP Kapitalforvaltning AS bought a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,300 shares of the technology company’s stock, valued at approximately $88,000. Other hedge funds and other institutional investors […] - 2025-04-11 04:44:59
- Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Consensus Rating of “Moderate Buy” from Analysts
- Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy […] - 2025-04-04 04:57:00
- Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Holdings Boosted by Intech Investment Management LLC
- Intech Investment Management LLC boosted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 99.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,657 shares of the technology company’s stock after buying an additional 28,233 shares during the quarter. […] - 2025-03-25 06:31:05
- Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by AlphaQuest LLC
- AlphaQuest LLC reduced its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 67.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,012 shares of the technology company’s stock after selling 16,970 shares during the quarter. AlphaQuest LLC’s holdings in Cogent Biosciences were […] - 2025-03-20 06:13:09
- Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts
- Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target […] - 2025-03-10 05:10:47
- Cogent Biosciences (NASDAQ:COGT) Now Covered by Scotiabank
- Scotiabank assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage issued a sector outperform rating and a $17.00 price objective on the technology company’s stock. COGT has been the subject of several other research reports. Wedbush reaffirmed a “neutral” rating and […] - 2025-03-10 03:50:48
- New York State Common Retirement Fund Acquires 2,200 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
- New York State Common Retirement Fund boosted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 10.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,102 shares of the technology company’s stock after purchasing an additional 2,200 shares […] - 2025-03-06 08:19:23
iShares MSCI World Small Cap UCITS ETF USD (Acc) COGT holdings
| Date | Number of COGT Shares Held | Base Market Value of COGT Shares | Local Market Value of COGT Shares | Change in COGT Shares Held | Change in COGT Base Value | Current Price per COGT Share Held | Previous Price per COGT Share Held |
|---|
| 2025-10-15 (Wednesday) | 59,534 | USD 986,478 | USD 986,478 | | | | |
| 2025-10-10 (Friday) | 59,162 | USD 962,566 | USD 962,566 | | | | |
| 2025-10-08 (Wednesday) | 59,162 | USD 921,744 | USD 921,744 | | | | |
| 2025-10-07 (Tuesday) | 59,162 | USD 913,461 | USD 913,461 | 248 | USD -23,272 | USD 15.44 | USD 15.9 |
| 2025-10-06 (Monday) | 58,914 | USD 936,733 | USD 936,733 | 0 | USD 8,248 | USD 15.9 | USD 15.76 |
| 2025-10-03 (Friday) | 58,914 | USD 928,485 | USD 928,485 | 0 | USD 59,503 | USD 15.76 | USD 14.75 |
| 2025-10-02 (Thursday) | 58,914 | USD 868,982 | USD 868,982 | 0 | USD 36,527 | USD 14.75 | USD 14.13 |
| 2025-10-01 (Wednesday) | 58,914 | USD 832,455 | USD 832,455 | 0 | USD -13,550 | USD 14.13 | USD 14.36 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of COGT by Blackrock for IE00BF4RFH31
Show aggregate share trades of COGT| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 248 | | | 15.440* | | 8.44 |
| 2025-09-08 | SELL | -504 | | | 12.680* | | 8.14 Profit of 4,103 on sale |
| 2025-08-15 | BUY | 250 | | | 11.890* | | 8.12 |
| 2025-07-29 | BUY | 248 | | | 11.840* | | 8.04 |
| 2025-07-14 | BUY | 508 | | | 11.090* | | 7.88 |
| 2025-06-30 | BUY | 524 | | | 7.180* | | 7.82 |
| 2025-06-25 | BUY | 780 | | | 7.070* | | 7.83 |
| 2025-06-20 | SELL | -133 | | | 7.230* | | 7.84 Profit of 1,042 on sale |
| 2025-06-12 | SELL | -1,064 | | | 7.220* | | 7.86 Profit of 8,362 on sale |
| 2025-06-02 | BUY | 420 | | | 5.610* | | 7.94 |
| 2025-05-28 | BUY | 280 | | | 4.880* | | 8.00 |
| 2025-05-14 | BUY | 138 | | | 4.880* | | 8.23 |
| 2025-05-13 | BUY | 278 | | | 4.990* | | 8.26 |
| 2025-05-07 | BUY | 408 | | | 4.720* | | 8.37 |
| 2025-04-28 | BUY | 139 | | | 4.910* | | 8.55 |
| 2025-04-16 | BUY | 1,807 | | | 4.270* | | 8.86 |
| 2025-04-14 | BUY | 278 | | | 4.580* | | 8.94 |
| 2025-04-08 | SELL | -278 | | | 4.140* | | 9.12 Profit of 2,535 on sale |
| 2025-04-04 | SELL | -280 | | | 4.770* | | 9.21 Profit of 2,578 on sale |
| 2025-03-28 | BUY | 1,350 | | | 6.480* | | 9.34 |
| 2025-03-12 | SELL | -270 | | | 7.590* | | 9.65 Profit of 2,605 on sale |
| 2025-03-04 | SELL | -266 | | | 7.170* | | 9.80 Profit of 2,607 on sale |
| 2025-02-26 | SELL | -532 | | | 6.710* | | 9.94 Profit of 5,291 on sale |
| 2025-02-13 | BUY | 135 | | | 8.180* | | 10.22 |
| 2025-02-12 | BUY | 536 | | | 8.140* | | 10.25 |
| 2025-01-27 | BUY | 131 | | | 8.470* | | 10.52 |
| 2025-01-23 | BUY | 132 | | | 8.890* | | 10.59 |
| 2024-12-09 | BUY | 4,824 | | | 9.670* | | 10.68 |
| 2024-12-04 | BUY | 264 | | | 9.210* | | 10.79 |
| 2024-12-03 | BUY | 393 | | | 9.190* | | 10.83 |
| 2024-11-19 | BUY | 798 | | | 9.060* | | 11.30 |
| 2024-11-18 | BUY | 264 | | | 8.990* | | 11.37 |
| 2024-11-12 | BUY | 516 | | | 10.380* | | 11.41 |
| 2024-11-11 | BUY | 129 | | | 10.400* | | 11.47 |
| 2024-11-11 | BUY | 129 | | | 10.400* | | 11.47 |
| 2024-11-07 | BUY | 635 | | | 10.050* | | 11.68 |
| 2024-11-07 | BUY | 635 | | | 10.050* | | 11.68 |
| 2024-10-23 | BUY | 248 | | | 12.300* | | 12.05 |
| 2024-10-23 | BUY | 248 | | | 12.300* | | 12.05 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of COGT
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 178,710 | 0 | 374,744 | 47.7% |
| 2025-09-18 | 144,303 | 0 | 492,031 | 29.3% |
| 2025-09-17 | 204,285 | 1 | 726,102 | 28.1% |
| 2025-09-16 | 150,691 | 0 | 462,672 | 32.6% |
| 2025-09-15 | 123,353 | 9,124 | 300,516 | 41.0% |
| 2025-09-12 | 450,700 | 3,878 | 931,716 | 48.4% |
| 2025-09-11 | 772,950 | 0 | 1,176,197 | 65.7% |
| 2025-09-10 | 261,353 | 0 | 456,012 | 57.3% |
| 2025-09-09 | 511,477 | 0 | 964,761 | 53.0% |
| 2025-09-08 | 209,439 | 0 | 470,138 | 44.5% |
| 2025-09-05 | 465,988 | 0 | 673,243 | 69.2% |
| 2025-09-04 | 181,762 | 0 | 430,780 | 42.2% |
| 2025-09-03 | 473,022 | 0 | 1,810,674 | 26.1% |
| 2025-09-02 | 176,868 | 2,239 | 441,974 | 40.0% |
| 2025-08-29 | 87,706 | 0 | 418,644 | 21.0% |
| 2025-08-28 | 148,192 | 0 | 494,102 | 30.0% |
| 2025-08-27 | 139,566 | 0 | 227,000 | 61.5% |
| 2025-08-26 | 98,499 | 0 | 159,127 | 61.9% |
| 2025-08-25 | 116,374 | 55 | 228,986 | 50.8% |
| 2025-08-22 | 116,232 | 0 | 299,050 | 38.9% |
| 2025-08-21 | 43,039 | 100 | 186,987 | 23.0% |
| 2025-08-20 | 128,443 | 146 | 178,217 | 72.1% |
| 2025-08-19 | 156,176 | 100 | 290,001 | 53.9% |
| 2025-08-18 | 350,319 | 0 | 521,654 | 67.2% |
| 2025-08-15 | 150,305 | 0 | 224,409 | 67.0% |
| 2025-08-14 | 177,013 | 0 | 478,177 | 37.0% |
| 2025-08-13 | 221,392 | 123 | 621,407 | 35.6% |
| 2025-08-12 | 173,664 | 0 | 323,917 | 53.6% |
| 2025-08-11 | 112,167 | 0 | 242,980 | 46.2% |
| 2025-08-08 | 214,099 | 0 | 398,838 | 53.7% |
| 2025-08-07 | 286,806 | 0 | 721,705 | 39.7% |
| 2025-08-06 | 199,883 | 19,134 | 622,043 | 32.1% |
| 2025-08-05 | 359,248 | 0 | 998,340 | 36.0% |
| 2025-08-04 | 172,949 | 11,386 | 344,270 | 50.2% |
| 2025-08-01 | 229,951 | 794 | 427,500 | 53.8% |
| 2025-07-31 | 232,840 | 127 | 882,862 | 26.4% |
| 2025-07-30 | 364,907 | 5,808 | 619,895 | 58.9% |
| 2025-07-29 | 136,763 | 40 | 415,525 | 32.9% |
| 2025-07-28 | 152,949 | 0 | 381,681 | 40.1% |
| 2025-07-25 | 297,157 | 0 | 584,570 | 50.8% |
| 2025-07-24 | 193,704 | 400 | 733,305 | 26.4% |
| 2025-07-23 | 452,121 | 619 | 1,363,605 | 33.2% |
| 2025-07-22 | 658,945 | 0 | 1,703,582 | 38.7% |
| 2025-07-21 | 363,053 | 62 | 886,644 | 40.9% |
| 2025-07-18 | 475,602 | 5,000 | 1,732,913 | 27.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.